Historical record - last NADAC effective date: 8/23/2023
Product Information
TRIMETHOPRIM 100 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.5684 per EA under NDC 43386033001. Its NADAC has been published 509 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386033001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
TRIMETHOPRIMApproval Type
Generic (ANDA)
FDA Application
ANDA091437FDA Approved
6/15/2011
TE Code
AB
On Market Since
6/24/2011
Pharmacological Classes
Price Statistics
The NADAC for TRIMETHOPRIM 100 MG TABLET has been published 509 times since Nov 28, 2013, and over the history we have for it it has risen 439.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5684 per EA |
|---|---|
| All-time high | $1.6187 (Aug 16, 2023) |
| All-time low | $0.2230 (Nov 21, 2018) |
| Median price | $0.2755 |
| Average price | $0.3765 |
| Largest weekly change | +182.6% (Oct 20, 2021) |
| Weeks tracked | 509 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+399.4%
All
+439.9%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trimethoprim market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydrofolate Reductase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIMETHOPRIM 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIMETHOPRIM 100 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $1.5684 per EA (NDC 43386033001), effective Aug 23, 2023.
How has the price of TRIMETHOPRIM 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIMETHOPRIM 100 MG TABLET has risen 439.9%. It has been tracked across 509 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIMETHOPRIM 100 MG TABLET?
Since Nov 28, 2013, the NADAC for TRIMETHOPRIM 100 MG TABLET has ranged from a low of $0.2230 (Nov 21, 2018) to a high of $1.6187 (Aug 16, 2023), with a median of $0.2755 per EA.
Are there cheaper alternatives to TRIMETHOPRIM 100 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIMETHOPRIM 100 MG TABLET, is $1.3068 per EA — about 17% below TRIMETHOPRIM 100 MG TABLET.
Who manufactures TRIMETHOPRIM 100 MG TABLET?
TRIMETHOPRIM 100 MG TABLET (NDC 43386033001) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.